Japan · Delayed Price · Currency is JPY MT Genex Statistics
Total Valuation
MT Genex has a market cap or net worth of JPY 4.17 billion. The enterprise value is 686.53 million.
| Market Cap | 4.17B |
| Enterprise Value | 686.53M |
Important Dates
The next confirmed earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
MT Genex has 1.08 million shares outstanding.
| Current Share Class | 1.08M |
| Shares Outstanding | 1.08M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 5.30% |
| Owned by Institutions (%) | 2.42% |
| Float | 269,466 |
Valuation Ratios
The trailing PE ratio is 9.56.
| PE Ratio | 9.56 |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | 77.23 |
| P/OCF Ratio | 54.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 0.95, with an EV/FCF ratio of 12.71.
| EV / Earnings | 1.57 |
| EV / Sales | 0.12 |
| EV / EBITDA | 0.95 |
| EV / EBIT | 1.04 |
| EV / FCF | 12.71 |
Financial Position
The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.21 |
| Quick Ratio | 3.77 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 1.43 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.09% and return on invested capital (ROIC) is 23.83%.
| Return on Equity (ROE) | 10.09% |
| Return on Assets (ROA) | 7.35% |
| Return on Invested Capital (ROIC) | 23.83% |
| Return on Capital Employed (ROCE) | 13.46% |
| Weighted Average Cost of Capital (WACC) | 5.41% |
| Revenue Per Employee | 38.37M |
| Profits Per Employee | 2.89M |
| Employee Count | 151 |
| Asset Turnover | 1.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MT Genex has paid 248.00 million in taxes.
| Income Tax | 248.00M |
| Effective Tax Rate | 36.26% |
Stock Price Statistics
The stock price has increased by +19.60% in the last 52 weeks. The beta is 0.23, so MT Genex's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +19.60% |
| 50-Day Moving Average | 3,729.30 |
| 200-Day Moving Average | 3,600.23 |
| Relative Strength Index (RSI) | 51.12 |
| Average Volume (20 Days) | 580 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MT Genex had revenue of JPY 5.79 billion and earned 436.00 million in profits. Earnings per share was 405.21.
| Revenue | 5.79B |
| Gross Profit | 1.30B |
| Operating Income | 659.00M |
| Pretax Income | 684.00M |
| Net Income | 436.00M |
| EBITDA | 725.25M |
| EBIT | 659.00M |
| Earnings Per Share (EPS) | 405.21 |
Balance Sheet
The company has 3.56 billion in cash and 77.00 million in debt, with a net cash position of 3.48 billion or 3,237.12 per share.
| Cash & Cash Equivalents | 3.56B |
| Total Debt | 77.00M |
| Net Cash | 3.48B |
| Net Cash Per Share | 3,237.12 |
| Equity (Book Value) | 4.52B |
| Book Value Per Share | 4,199.71 |
| Working Capital | 4.39B |
Cash Flow
In the last 12 months, operating cash flow was 76.00 million and capital expenditures -22.00 million, giving a free cash flow of 54.00 million.
| Operating Cash Flow | 76.00M |
| Capital Expenditures | -22.00M |
| Depreciation & Amortization | 66.25M |
| Net Borrowing | -17.00M |
| Free Cash Flow | 54.00M |
| FCF Per Share | 50.17 |
Margins
Gross margin is 22.37%, with operating and profit margins of 11.37% and 7.53%.
| Gross Margin | 22.37% |
| Operating Margin | 11.37% |
| Pretax Margin | 11.81% |
| Profit Margin | 7.53% |
| EBITDA Margin | 12.52% |
| EBIT Margin | 11.37% |
| FCF Margin | 1.15% |
Dividends & Yields
This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 1.03%.
| Dividend Per Share | 40.00 |
| Dividend Yield | 1.03% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 79.72% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.03% |
| Earnings Yield | 10.45% |
| FCF Yield | 1.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2017. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
MT Genex has an Altman Z-Score of 4.17 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.17 |
| Piotroski F-Score | 5 |